These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22857990)

  • 1. White matter lesions and depression in patients with Parkinson's disease.
    Petrovic IN; Stefanova E; Kozic D; Semnic R; Markovic V; Daragasevic NT; Kostic VS
    J Neurol Sci; 2012 Nov; 322(1-2):132-6. PubMed ID: 22857990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual rating of white matter hyperintensities in Parkinson's disease.
    Beyer MK; Aarsland D; Greve OJ; Larsen JP
    Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional patterns of brain tissue loss associated with depression in Parkinson disease.
    Kostić VS; Agosta F; Petrović I; Galantucci S; Spica V; Jecmenica-Lukic M; Filippi M
    Neurology; 2010 Sep; 75(10):857-63. PubMed ID: 20686125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression.
    Nebes RD; Vora IJ; Meltzer CC; Fukui MB; Williams RL; Kamboh MI; Saxton J; Houck PR; DeKosky ST; Reynolds CF
    Am J Psychiatry; 2001 Jun; 158(6):878-84. PubMed ID: 11384894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
    Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
    Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities in patients with multiple system atrophy.
    Umoto M; Miwa H; Ando R; Kajimoto Y; Kondo T
    Parkinsonism Relat Disord; 2012 Jan; 18(1):17-20. PubMed ID: 21868276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with cerebral white matter hyperintensities in haemodialysis patients.
    Naganuma T; Takemoto Y; Shoji T; Shima H; Ishimura E; Okamura M; Nakatani T
    Nephrology (Carlton); 2012 Aug; 17(6):561-8. PubMed ID: 22429518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals.
    Wen W; Sachdev P
    Neuroimage; 2004 May; 22(1):144-54. PubMed ID: 15110004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.
    Dotson VM; Zonderman AB; Kraut MA; Resnick SM
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):66-74. PubMed ID: 22415749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI.
    Wen W; Sachdev P; Shnier R; Brodaty H
    Neuroimage; 2004 Apr; 21(4):1350-6. PubMed ID: 15050560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensity progression and late-life depression outcomes.
    Taylor WD; Steffens DC; MacFall JR; McQuoid DR; Payne ME; Provenzale JM; Krishnan KR
    Arch Gen Psychiatry; 2003 Nov; 60(11):1090-6. PubMed ID: 14609884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities.
    Park JH; Kwon HM; Lee J; Kim DS; Ovbiagele B
    Eur J Neurol; 2015 Jan; 22(1):44-52, e2-3. PubMed ID: 24712717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
    González-Redondo R; Toledo J; Clavero P; Lamet I; García-García D; García-Eulate R; Martínez-Lage P; Rodríguez-Oroz MC
    Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities and chronicity of depression.
    Heiden A; Kettenbach J; Fischer P; Schein B; Ba-Ssalamah A; Frey R; Naderi MM; Gulesserian T; Schmid D; Trattnig S; Imhof H; Kasper S
    J Psychiatr Res; 2005 May; 39(3):285-93. PubMed ID: 15725427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression.
    Dalby RB; Chakravarty MM; Ahdidan J; Sørensen L; Frandsen J; Jonsdottir KY; Tehrani E; Rosenberg R; Ostergaard L; Videbech P
    Psychol Med; 2010 Aug; 40(8):1389-99. PubMed ID: 19895719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities and rating scales-observer reliability varies with lesion load.
    Wardlaw JM; Ferguson KJ; Graham C
    J Neurol; 2004 May; 251(5):584-90. PubMed ID: 15164192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.